Opioid Treatment Program Medicare Billing Audit: Bundled Payment and Take-Home Dose Documentation

How Medicare pays opioid treatment programs through weekly bundles and add-on codes, what OIG found in OTP audits, and how to document take-home doses, intake, assessments, and counseling.

KNOWLEDGE CENTER

11/15/202612 min read

Since January 1, 2020, Medicare Part B has covered opioid use disorder (OUD) treatment services furnished by opioid treatment programs (OTPs). The benefit was created by the SUPPORT for Patients and Communities Act and is implemented at 42 CFR 410.67. Medicare pays OTPs primarily through weekly bundled payments that cover medication, its dispensing or administration, counseling, individual and group therapy, and toxicology testing, with add-on codes for intake, periodic assessments, take-home medication supplies, additional counseling, and other services.

The bundled design gives OTPs flexibility, but it also creates compliance risks that differ from ordinary fee-for-service billing. A bundle is paid for a week of care, so auditors look at whether the services that justify the bundle were actually furnished and documented. Add-on codes have their own conditions, and take-home medication add-ons must line up with federal OTP rules on unsupervised doses. The U.S. Department of Health and Human Services Office of Inspector General (OIG) has audited Medicare OTP payments twice, finding up to $17.8 million in potentially improper payments in one report and estimating in another that Medicare could have saved $301.5 million if bundled rates had reflected the services actually furnished.

This article explains how Medicare OTP billing works, what OIG found, how federal take-home rules changed in 2024, and how OTPs can document bundled services and take-home doses to withstand review. It is educational and neutral. OTPs should confirm current requirements with CMS manuals, the annual Physician Fee Schedule rule, and their Medicare Administrative Contractor (MAC).

The Medicare OTP Benefit at a Glance

Who Can Bill

To bill Medicare for OUD treatment services, an OTP must be certified by the Substance Abuse and Mental Health Services Administration (SAMHSA) under 42 CFR Part 8, accredited by a SAMHSA-approved accrediting body, registered with the Drug Enforcement Administration, and enrolled in Medicare as an OTP.

What the Bundle Includes

According to CMS's claims processing instructions, Medicare uses weekly bundled codes for each medication type: G2067 for methadone, G2068 for oral buprenorphine, G0533 for a weekly injectable buprenorphine bundle, G2069 for the monthly injectable buprenorphine bundle, G2073 for naltrexone, and G2075 for medication not otherwise specified. G2074 is a non-drug weekly bundle covering substance use counseling, individual and group therapy, and toxicology testing if performed, without the drug.

Add-On Codes

CMS describes add-on codes that adjust the bundled payment, including:

• G2076 for intake activities, which CMS states should only be billed for new patients starting treatment at the OTP.

• G2077 for periodic assessments after intake.

• G2078 for a take-home supply of methadone, up to an additional 7-day supply.

• G2079 for a take-home supply of oral buprenorphine, up to an additional 7-day supply.

• G2080 for each additional 30 minutes of counseling or therapy, billable when services substantially exceed the amount specified in the patient's individualized treatment plan, with medical necessity documented in the record.

• Codes for take-home naloxone and nalmefene.

• G0137 for intensive outpatient services furnished by OTPs, which requires a certification of need for a minimum number of hours of services per week.

• G0534, G0535, and G0536 for coordinated care and referral services, patient navigation, and peer recovery support services, which CMS expects OTPs to document in the patient's care plan.

CMS updated the OTP sections of the Medicare Benefit Policy Manual and Claims Processing Manual in March 2026 to reflect changes in the CY 2026 Physician Fee Schedule final rule, effective for dates of service on or after January 1, 2026. OTPs should review the current manual sections and the annual rule each year, because codes, payment rates, and conditions change.

What OIG Found

Potentially Improper Payments

In August 2023, OIG reported on 2.1 million Medicare Part B claims for OUD treatment services provided to more than 40,000 enrollees from January 2020 through September 2021, for which Medicare paid $364.1 million. OIG found that Medicare made up to $17.8 million in potentially improper payments to OTPs. The categories included $10.4 million for weekly bundles that overlapped with other payments for the same enrollee at the same OTP, $1.3 million for OUD treatment services claimed without an OUD diagnosis, and $1 million for intake activities billed 14 or more times for the same enrollee during the audit period. OIG attributed some of these payments to the absence of system edits. OIG noted that its findings constituted credible information of potential overpayments, which triggers provider obligations to investigate.

Bundled Rates Versus Services Furnished

In October 2025, OIG reported that Medicare could have saved $301.5 million, 53 percent of $564.6 million in total payments, if bundled payment rates had reflected the types and frequency of OUD treatment services actually provided to enrollees. For 89 of 100 sample items, the bundled payment exceeded the amount OIG calculated based on services actually furnished. OIG recommended that CMS consider the results in future rulemaking and work with SAMHSA or a designated agency to monitor whether OTPs properly document OUD treatment services in enrollees' treatment plans.

What This Means for OTPs

The 2025 report was directed at CMS's payment methodology, not at individual OTPs. But it signals that oversight bodies are examining whether the services that justify a weekly bundle are actually delivered. An OTP that bills a full weekly bundle while furnishing little beyond medication may face questions about whether the bundle was supported, particularly where counseling required by the treatment plan was not furnished.

Medicaid Audits Show the Same Themes

OIG's Medicaid OTP audits in New York, New Hampshire, California, and Washington identified treatment plans that were missing, untimely, or not reviewed by qualified staff, counseling that was not furnished as planned, and missing documentation. Because Medicare relies on the same federal OTP standards, those themes apply to Medicare billing as well.

Billing the Weekly Bundle Correctly

One Bundle per Week per Patient

A weekly bundle covers a contiguous seven-day period. Billing overlapping bundles for the same patient, or billing a bundle and separately billing services included in it, creates duplicate payment. OIG's finding of $10.4 million in overlapping bundles shows how easily this happens when episodes are not tracked carefully.

Choosing the Right Bundle

The bundle should match the medication actually furnished during the week. If a patient switches medications, the change should be documented and the bundle code should follow the medication. When no medication is furnished but counseling and other services are, the non-drug bundle may apply.

Supporting the Bundle

Medicare's bundle includes counseling, therapy, and toxicology testing as part of the episode. While CMS does not require every component in every week, the record should show the services furnished during each billed week and how they relate to the treatment plan. A week in which the patient received nothing, or received medication without the counseling the plan called for and without documented clinical reasons, is vulnerable on review.

Diagnosis

Every claim must carry an OUD diagnosis supported by the record. OIG found payments for services claimed without one.

Partial Weeks and Discharges

OTPs should follow CMS instructions on billing when a patient begins or ends treatment mid-week, is hospitalized, or misses doses. Billing a full bundle for a week in which the patient was not under the OTP's care is improper.

Intake and Periodic Assessment Add-Ons

CMS states that the intake add-on should only be billed for new patients starting treatment at the OTP, and that later assessments are billed as periodic assessments. OIG found intake activities billed 14 or more times for the same enrollee. OTPs should configure billing systems to prevent repeated intake billing and should document when a returning patient is treated as new under program policy.

Both intake and periodic assessments must meet SAMHSA certification requirements for evidence-based assessments in 42 CFR Part 8. CMS does not require a specific assessment tool, but the record should show what was assessed, by whom, and the clinical conclusions.

Counseling and the G2080 Add-On

The G2080 add-on is for counseling or therapy that substantially exceeds the amount in the individualized treatment plan. It is not for routine counseling, which is already included in the bundle. To bill it, the record should show the planned counseling amount, the additional time actually furnished, and the medical necessity for the additional services.

Take-Home Doses: The Federal Rules

The 2024 Part 8 Final Rule

In February 2024, SAMHSA finalized major revisions to 42 CFR Part 8. The rule took effect April 2, 2024, with a compliance date of October 2, 2024. Among other changes, it made permanent the expanded take-home flexibilities first allowed during the COVID-19 public health emergency and revised the criteria for unsupervised take-home doses of methadone, moving from rigid time-in-treatment rules toward clinical judgment using a risk-benefit framework.

Under the final rule, patients may receive:

• Up to 7 take-home doses during the first 14 days of treatment.

• Up to 14 take-home doses from day 15 of treatment.

• Up to 28 take-home doses from day 31 of treatment.

SAMHSA has emphasized that the decision to provide take-home doses rests with the treating practitioner, based on the factors in the rule. States may impose stricter requirements, and OTPs must follow both federal and state rules.

Clinical Documentation of Take-Home Decisions

Because take-home decisions now depend on clinical judgment, documentation of that judgment is essential. For each take-home decision, the record should show:

• The treating practitioner who made the decision.

• The factors considered under 42 CFR Part 8, such as absence of active substance use or other misuse that would make take-homes unsafe, regularity of attendance, absence of serious behavioral problems, absence of recent diversion, the stability of the home environment, ability to store medication safely, and the patient's ability to comply.

• The number of take-home doses authorized and the reason.

• Patient education on safe storage and the risks of diversion and accidental exposure, including for children.

• Safe storage arrangements, such as a lockbox where required.

• Reassessment at appropriate intervals and changes when risk changes.

• Diversion control measures, such as callbacks or bottle checks, where used.

Linking Take-Homes to Medicare Billing

The Medicare take-home add-ons, G2078 for methadone and G2079 for oral buprenorphine, each represent up to an additional 7-day supply. According to CMS's manual, they may be billed in units of up to three with the corresponding weekly bundle, and only with the matching bundle code (G2078 only with G2067; G2079 only with G2068). CMS states that because SAMHSA allows up to one month of take-home medication, it does not expect the add-on codes to be billed more than three times in one month.

For each add-on billed, the record should show:

• The practitioner's take-home order and the clinical justification under Part 8.

• The number of doses dispensed and the dates covered.

• Dispensing records that match the units billed.

• That the take-home supply falls within the federal limits for the patient's time in treatment and any stricter state limits.

Billing take-home add-ons for doses not dispensed, for more days than authorized, or with the wrong bundle code creates overpayments. Billing patterns in which almost every patient receives the maximum take-home add-ons regardless of time in treatment will draw attention.

Treatment Plans and Progress Documentation

Federal OTP standards require individualized treatment plans that are reviewed and updated at required intervals. OIG has repeatedly found missing or late treatment plan reviews and has recommended that OTPs show through documentation that plans and progress notes are reviewed by qualified staff. For Medicare, the treatment plan is also the reference point for whether bundled counseling was furnished and whether the G2080 add-on is justified.

Each treatment plan should include the patient's goals, the medication and dose, the planned counseling and therapy, the planned toxicology testing, the take-home plan, coordination with other providers, and the signatures and review dates required by federal and state rules.

Toxicology Testing Within the Bundle

Medicare's weekly bundle includes toxicology testing if performed. OTPs and affiliated laboratories should not separately bill Medicare for testing included in the bundle. Testing should still be individualized and its results used in care decisions, including take-home decisions.

Telehealth

Medicare permits certain OTP services, including some counseling, therapy, and periodic assessments, to be furnished by telecommunications under conditions CMS specifies, and federal OTP rules permit some initiation of buprenorphine and other activities by telehealth. Telehealth flexibilities have changed several times, so OTPs should keep a dated record of the rules in effect for each period and document the modality used for each service.

Building an OTP Medicare Compliance Program

Configure Billing Edits

Set system edits that prevent overlapping bundles, repeated intake add-ons, take-home add-ons with the wrong bundle, more than three take-home add-on units per bundle, and claims without an OUD diagnosis.

Track Episodes

Maintain a patient episode calendar that shows each billed week, the bundle code, medication furnished, services delivered, and add-ons billed.

Monitor Take-Home Decisions

Review take-home authorizations monthly for documented clinical justification, compliance with federal and state limits, and alignment with dispensing and billing.

Audit Treatment Plans

Track treatment plan review dates and confirm that counseling furnished matches the plan.

Audit Claims

Sample weekly bundles and add-ons each month and test them against the record. Track error rates by code.

Train Staff

Train clinicians, nurses, counselors, and billing staff on Medicare OTP codes, Part 8 take-home criteria, and documentation expectations.

Return Overpayments

When reviews identify overpayments, report and return them under the Medicare overpayment rules at 42 CFR Part 401, Subpart D, and section 1128J(d) of the Social Security Act. OIG has noted that its findings can constitute credible information of potential overpayments that providers must investigate.

Responding to a Medicare OTP Audit

• Identify the auditor, such as a MAC, Unified Program Integrity Contractor, Recovery Audit Contractor, or OIG, and the review type.

• Calendar response deadlines, which can be short.

• Assemble, for each sampled week, the bundle claim, medication administration and dispensing records, counseling and therapy notes, toxicology results, treatment plan in effect, and take-home documentation.

• For add-ons, assemble intake or assessment documentation, counseling time records, and take-home orders and dispensing logs.

• Confirm the OUD diagnosis and Medicare enrollment status for each date.

• Conduct a pre-submission review and address any overpayments.

• Respond claim by claim to findings and use the Medicare appeals process where appropriate: redetermination, reconsideration, administrative law judge hearing, Medicare Appeals Council, and federal court.

• Scrutinize any statistical extrapolation.

Dually Eligible Patients and Coordination With Medicaid

Many OTP patients are enrolled in both Medicare and Medicaid. Medicare is generally the primary payer for covered OTP services, with Medicaid paying secondary according to state rules. OTPs should verify coverage at intake and periodically, bill Medicare first where required, and make sure Medicaid crossover claims are consistent with the Medicare claim. Billing Medicaid as primary for a Medicare-covered service, or billing both programs for the same week of care, can create overpayments in either program.

Myths About OTP Medicare Billing

Myth: The Bundle Pays for Medication, So Counseling Is Optional

The bundle includes counseling and therapy. Weeks without planned counseling and without documented reasons are vulnerable.

Myth: Take-Home Add-Ons Can Be Billed for Every Week

Add-ons require take-home doses actually dispensed under a documented clinical decision that complies with Part 8 and state limits, billed with the correct bundle and within CMS's unit limits.

Myth: Intake Can Be Billed Whenever a Patient Returns

CMS states intake is for new patients starting treatment at the OTP; subsequent assessments are periodic assessments.

Myth: The OIG Bundled Rate Report Does Not Affect Providers

The report targeted CMS's methodology, but its recommendation for monitoring OTP documentation signals closer review of whether bundled services are furnished.

Questions Leadership Should Ask

• Do our systems prevent overlapping bundles and repeated intake add-ons?

• Does every billed week have documentation of the services furnished?

• Are take-home decisions documented with Part 8 factors and matched to dispensing and billing?

• How often are we billing the maximum take-home add-ons, and is it justified?

• Are treatment plans reviewed on time and is counseling furnished as planned?

• Are we billing toxicology testing separately when it is bundled?

• What is our internal audit error rate by code?

Key Takeaways

• Medicare pays OTPs through weekly bundles with add-on codes for intake, periodic assessments, take-home supplies, additional counseling, and other services, under 42 CFR 410.67.

• OIG found up to $17.8 million in potentially improper OTP payments, including overlapping bundles, services without an OUD diagnosis, and repeated intake billing, and estimated Medicare could have saved $301.5 million if bundles reflected services furnished.

• The 2024 Part 8 rule allows up to 7, 14, and 28 take-home doses at defined points in treatment, based on documented clinical judgment.

• Medicare take-home add-ons G2078 and G2079 may be billed in units of up to three with the matching bundle, and CMS does not expect more than three per month.

• Billing edits, episode tracking, take-home monitoring, treatment plan audits, and claim sampling are the core safeguards.

How HealthBridge Can Help

HealthBridge helps opioid treatment programs build Medicare billing and documentation practices that hold up under review. Our team can audit a sample of weekly bundles and add-on codes against medication, counseling, testing, and treatment plan documentation; review take-home authorizations against 42 CFR Part 8 criteria, state rules, dispensing records, and billed units; and identify system gaps that allow overlapping bundles or repeated intake billing. We help OTPs configure billing edits, design episode tracking and take-home documentation templates, train clinical and billing staff, and build internal audit and overpayment processes. When a Medicare contractor or OIG requests records, we can help organize the response and prepare appeals. If your OTP wants to strengthen Medicare bundled payment and take-home documentation, please get in touch with us. We will be happy to help you with this topic.

References

• Electronic Code of Federal Regulations. 42 CFR 410.67, Medicare coverage and payment of opioid use disorder treatment services furnished by opioid treatment programs. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-410/subpart-B/section-410.67

• Electronic Code of Federal Regulations. 42 CFR Part 8, Medications for the Treatment of Opioid Use Disorder. https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-8

• Federal Register. Medications for the Treatment of Opioid Use Disorder, Final Rule (February 2, 2024). https://www.federalregister.gov/documents/2024/02/02/2024-01693/medications-for-the-treatment-of-opioid-use-disorder

• Substance Abuse and Mental Health Services Administration. The 42 CFR Part 8 Final Rule Table of Changes. https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8/changes

• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 39, Opioid Treatment Programs (Transmittal R13572CP, March 3, 2026). https://www.cms.gov/files/document/r13572cp.pdf

• Centers for Medicare & Medicaid Services. Transmittal R13572BP, Updates to Medicare Benefit Policy Manual and Medicare Claims Processing Manual for Opioid Treatment Programs. https://www.cms.gov/medicare/regulations-guidance/transmittals/2026-transmittals/r13572bp

• Centers for Medicare & Medicaid Services. Final Rule Payment Rates for Opioid Treatment Programs. https://www.cms.gov/medicare/opioid-treatment-programs-otp/billing-payment/otp-payment-rates

• Federal Register. CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies, Final Rule (November 5, 2025). https://www.govinfo.gov/content/pkg/FR-2025-11-05/html/2025-19787.htm

• HHS Office of Inspector General. Medicare Made $17.8 Million in Potentially Improper Payments for Opioid-Use-Disorder Treatment Services Furnished by Opioid Treatment Programs (A-09-22-03005). https://oig.hhs.gov/reports/all/2023/medicare-made-178-million-in-potentially-improper-payments-for-opioid-use-disorder-treatment-services-furnished-by-opioid-treatment-programs

• HHS Office of Inspector General. Medicare Could Have Saved $301.5 Million if Bundled Payment Rates for Opioid-Use-Disorder Treatment Services Had Reflected Services Provided to Enrollees (A-09-23-03002). https://oig.hhs.gov/reports/all/2025/medicare-could-have-saved-3015-million-if-bundled-payment-rates-for-opioid-use-disorder-treatment-services-had-reflected-services-provided-to-enrollees/

• HHS Office of Inspector General. Opioid Treatment Programs in Washington State Did Not Fully Comply With Federal and State Requirements (A-09-21-02001). https://oig.hhs.gov/reports/all/2024/opioid-treatment-programs-in-washington-state-did-not-fully-comply-with-federal-and-state-requirements-which-may-have-put-medicaid-enrollees-at-risk-for-poor-treatment-outcomes

• Electronic Code of Federal Regulations. 42 CFR Part 401, Subpart D, Requirements for the Return and Reporting of Overpayments. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-A/part-401/subpart-D

• U.S. Code. 42 U.S.C. 1320a-7k(d), Reporting and returning of overpayments. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section1320a-7k

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.

The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.

HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.

© 2026 HealthBridge US, a California corporation. All rights reserved.

For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance

Legal

Resources